Expression of tissue inhibitor of metalloproteinases-1 and b-cell lymphoma-2 in the synovial membrane in patients with knee osteoarthritis

12Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

The purpose of this study was to determine the expression and impact of tissue inhibitor of metalloproteinases-1 (TIMP-1) and B-cell lymphoma-2 (Bcl-2) in knee osteoarthritis (KOA). We collected synovial fluids from the knee joint of 70 KOA patients and 30 controls. The expression levels of TIMP-1 and Bcl-2 were significantly higher in KOA patients than those in the control group (P<0.01). We also found positive correlation between the severity of KOA and the expression level of TIMP-1 (r=0.8027, P<0.05) and and Bcl-2 (r=0.5336, P<0.05). However, we found no correlation between the expression levels of TIMP-1 and Bcl-2 in the synovial membranes of KOA patients (P>0.05). Both TIMP-1 and Bcl-2 are expressed at high levels in the synovial membrane with KOA, and are closely related to the occurrence and development of KOA. Thus, detection of TIMP-1 and Bcl-2 in KOA patients can be helpful in diagnosing the state of KOA.

Cite

CITATION STYLE

APA

Li, X., Fu, X., Gao, Y., Li, H., Wang, W., & Shen, Y. (2018). Expression of tissue inhibitor of metalloproteinases-1 and b-cell lymphoma-2 in the synovial membrane in patients with knee osteoarthritis. Experimental and Therapeutic Medicine, 15(1), 885–889. https://doi.org/10.3892/etm.2017.5462

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free